Adalimumab/infliximabDevelopment of drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1893卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09801-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[31] AzithromycinDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1790 (1) : 58 - 58
[32] OsimertinibAcquired drug resistance: case report
Reactions Weekly, 2019, 1781 (1) : 276 - 276
[33] CrizotinibAcquired drug resistance: case report
Reactions Weekly, 2023, 1958 (1) : 167 - 167
[34] MeropenemAcquired drug resistance: case report
Reactions Weekly, 2021, 1839 (1) : 184 - 184
[35] IcotinibDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1822 (1) : 157 - 157
[36] PralsetinibAcquired drug resistance : case report
Reactions Weekly, 2024, 2035 (1) : 426 - 426
[37] AciclovirAcquired drug resistance: case report
Reactions Weekly, 2022, 1894 (1) : 17 - 17
[38] InsulinDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1831 (1) : 166 - 166
[39] AntineoplasticsDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1812 (1) : 34 - 34
[40] DaptomycinEmergence of drug resistance: case report
Reactions Weekly, 2019, 1776 (1) : 150 - 150

← 1 2 3 4 5 →